ABSTRACT
ABSTRACT Background: Acute hepatic porphyrias represent an expanding group of complex inherited metabolic disorders due to inborn errors of metabolism involving heme biosynthesis. Objective: We aimed to review the main clinical and therapeutic aspects associated with acute hepatic porphyrias. Methods: The authors provided a wide non-systematic review of current concepts and recently acquired knowledge about acute hepatic porphyrias. Results: Acute neurovisceral attacks are the most common and life-threatening presentation of this group and are often considered the main clinical manifestation by clinicians during differential diagnosis and the start of proper diagnostic work-up for acute porphyrias. However, atypical presentations with central nervous system involvement, neuropsychiatric disturbances, and some subtypes with photosensitivity usually make the definite diagnosis difficult and late. Early therapeutic interventions are essential during emergency treatment and intercritical periods to avoid recurrent severe presentations. The availability of new disease-modifying therapeutic proposals based on small interfering RNA (siRNA)-based therapies, complementary to the classic intravenous glucose infusion and hemin-based treatments, emphasizes the importance of early diagnosis and genetic counseling of patients. Conclusions: This review article highlights the main biochemical, pathophysiological, clinical, and therapeutic aspects of acute hepatic porphyrias in clinical practice.
RESUMO Introdução: As porfirias hepáticas agudas representam um grupo de doenças metabólicas hereditárias complexas em expansão, decorrentes de erros inatos do metabolismo, envolvendo a via de biossíntese do grupamento heme. Objetivo: realizar revisão dos principais aspectos clínicos e terapêuticos associados com as porfirias hepáticas agudas. Métodos: Os autores realizaram ampla revisão não-sistemática sobre conceitos atuais e conhecimentos recentemente adquiridos. Resultados: Ataques neuroviscerais agudos representam a apresentação clínica mais comum e de maior risco, e são comumente considerados como principal manifestação na prática clínica durante o diagnóstico diferencial e início apropriado da investigação diagnóstica para porfirias agudas. Entretanto, apresentações atípicas com envolvimento do sistema nervoso central, alterações neuropsiquiátricas e alguns subtipos com fotossensibilidade fazem com que o diagnóstico definitivo seja comumente difícil e tardio. As intervenções terapêuticas precoces são essenciais durante o tratamento emergencial e em período intercrítico evitando formas recorrentes graves. A disponibilidade de novas propostas terapêuticas modificadoras de doença baseadas em terapias com pequenas moléculas de RNA de interferência (siRNA) complementares aos clássicos tratamentos com infusão de glicose intravenosa e à base de hemina enfatiza a importância do diagnóstico precoce de tais pacientes e do aconselhamento genético. Conclusões: Este artigo de revisão destaca os principais aspectos bioquímicos, fisiopatológicos, clínicos e terapêuticos das porfirias hepáticas agudas na prática clínica.
Subject(s)
Porphyrias, Hepatic , Porphyria, Acute Intermittent/diagnosis , Porphyria, Acute Intermittent/therapy , RNA, Small Interfering , Neurologists , Porphobilinogen SynthaseABSTRACT
ABSTRACT The present study investigated the antioxidant effect of a new class of quinoline derivatives (a-d) on assays in vitro. Lipid peroxidation, thiol peroxidase-like and free radical scavenging activities were determined to evaluate antioxidant activity of compounds. Thiol oxidase-like and δ-aminolevulinate dehydratase activities were performed as a toxicological parameter. A second objective of this study was to evaluate the in vivo antinociceptive effect of the compound with better antioxidant effect and without toxic effects in a model of nociception induced by formalin in mice. In liver, at 100 µM, compound a reduced the lipid peroxidation to the control levels, while compounds c and d partially reduced it. In brain, only compound d partially reduced the lipid peroxidation at 50 and 100 µM. Compound b did not have an effect on the lipid peroxidation. Thiol peroxidase-like and free radical scavenging activities are not involved in the antioxidant mechanisms of these compounds. Compounds did not present thiol oxidase-like activity and effect on the δ-aminolevulinate dehydratase. In vivo experiments showed that compound a caused an inhibition of licking time in the first and second phases, and edema formation induced by formalin. In conclusion, quinoline derivative without selenium presented better in vitro antioxidant effect and in vivo antinociceptive activity.
Subject(s)
Animals , Male , Rats , Quinolines/pharmacology , Selenium/pharmacology , Oxidative Stress/drug effects , Analgesics/pharmacology , Antioxidants/pharmacology , Oxidation-Reduction , Quinolines/chemistry , Pain Measurement , Free Radical Scavengers , Disease Models, Animal , Oxidoreductases Acting on Sulfur Group Donors/pharmacology , Porphobilinogen Synthase/pharmacologyABSTRACT
Lead is an environmental pollutant having nephrotoxic effects even at low level. Its continuous exposure is associated with increased serum uric acid level that resulting in renal insufficiency. This research was conducted to see the effects of delta-aminolevulinic acid dehydratase [ALAD] and vitamin D receptor [VDR] genotypes on biochemical parameters and blood pressure [BP] of automobile workers having low blood lead level [BLL] with continuous lead exposure. Automobile paints workers with ALAD 1-2 genotype showed the positive association of BLL with diastolic BP [p<0.05] whereas, a genotypic combination ofALAD -2IVDR BB showed the negative association of serum uric acid with BLL [p<0.05]. Similarly negative effects of VDR BB genotype [p<0.01] and ALAD 1-2 genotype [p<0.05] were observed in the association of serum uric acid with BLL at the mean age >30 years. This suggests that automobile paint workers having ALAD 1-2 genotypes are at the risk of increased diastolic BP. The research also foretells that combination of ALAD -2IVDR BB may play a significant role against lead induced nephrotoxicity at low BLL with continuous lead exposure
Subject(s)
Humans , Male , Adult , Lead Poisoning , Occupational Diseases , Uric Acid/blood , Blood Pressure , Renal Insufficiency , Porphobilinogen Synthase , Receptors, Calcitriol , Automobiles , Health Personnel , Paint , Cross-Sectional StudiesABSTRACT
<p><b>OBJECTIVE</b>To investigate the lead exposure, its effects, and the relationships between biomarkers of susceptibility in the workers with low-level occupational lead exposure, and to explore its sensitivity and practical value to evaluate the health hazard.</p><p><b>METHODS</b>The concentrations of lead fume and lead dust in workplaces of a lead acid storage battery enterprise in Jiangsu Province, China, were measured by occupational health monitoring method. The blood samples of 233 workers with occupational lead exposure and 76 non-occupational lead exposure were collected to measure the blood lead (Pb-B) level using graphite furnace atomic absorption spectrometry (GFAAS), the zinc Protoporphyrin (ZPP) level with blood fluorescence assay, and the delta-aminolevulinic acid dehydratase (ALAD) concentration by a spectrophotometer, and to determine the gene polymorphism of ALAD with TaqMan real-time polymerase chain reaction. At the same time, their urine samples were collected to measure urine lead (Pb-U) concentration with GFAAS and delta-aminolevulinic acid (ALA-U) concentration with a spectrophotometer. The correlations between the above indices were analyzed by multiple linear regression method.</p><p><b>RESULTS</b>The concentration of lead fume in 18 testing sites and the concentration of lead dust in 30 testing sites were 0.002-0.019 mg/m3 and 0.004-0.013 mg/m3, respectively. Pb-B level was positively correlated with Pb-U concentration (r=0.62, P<0.01) and ZPP level (r=0.47, P<0.01) and was negatively correlated with ALAD concentration (r=-0.77, P<0.01) in 233 workers with occupational lead exposure. Among 233 workers, 218 (93.6%) had ≤70 µg/L Pb-U, and 15 (6.9%) had ≥400≥g/L Pb-B. Pb-B level was not correlated with ZPP level as Pb-B level was <190 µg/L (r=0.18, P=0.068 ), while Pb-B level was positively correlated with ZPP level as Pb-B level was ≥190 µg/L (r=0.36, P<0.01). Pb-U concentration was positively correlated with ALA-U concentration (r=0.49, P<0.01) and ZPP level (r=0.47, P<0.01). ZPP level was negatively correlated with ALAD concentration (r=-0. 19, P<0.01), and was positively correlated with ALA-U concentration (r=0.27, P<0.01). ALAD concentration was not correlated with ALA-U concentration (r =-0. 11, P>0.05). And in 233 workers with occupational lead exposure, there were no significant differences in Pb-B level, ZPP level, and ALAD activity between the workers with ALAD1-2 genotype and the workers with ALAD1-1 genotype (P>0.05). In 76 workers with non-occupational lead exposure, there was no significant difference in Pb-B level between the workers with ALAD1-2 genotype and the workers with ALAD1-1 genotype (P >0.05). The workers with ALAD1-2 genotype had a significantly lower ALAD activity, and a significantly higher ZPP level compared with those ALAD1-1 genotype (P<0.01).</p><p><b>CONCLUSION</b>In the workers with low-level occupational lead exposure, ZPP level is positively correlated with Pb-B level when Pb-B level was ≥190 µ/L. ALAD could be used as an effect biomarker of low Pb-B level. ALAD gene polymorphism shows different effects on the Pb-B level and the toxic effects between the workers with occupational lead exposure and the workers with non-occupational lead exposure.</p>
Subject(s)
Humans , Aminolevulinic Acid , Blood , Biomarkers , Blood , China , Electric Power Supplies , Genotype , Lead , Blood , Linear Models , Occupational Exposure , Polymorphism, Genetic , Porphobilinogen Synthase , Blood , Genetics , Protoporphyrins , BloodABSTRACT
The pharmacology of synthetic organoselenium compounds indicates that they can be used as antioxidants, enzyme inhibitors, neuroprotectors, anti-tumor and anti-infectious agents, and immunomodulators. In this review, we focus on the effects of diphenyl diselenide (DPDS) in various biological model organisms. DPDS possesses antioxidant activity, confirmed in several in vitro and in vivo systems, and thus has a protective effect against hepatic, renal and gastric injuries, in addition to its neuroprotective activity. The activity of the compound on the central nervous system has been studied since DPDS has lipophilic characteristics, increasing adenylyl cyclase activity and inhibiting glutamate and MK-801 binding to rat synaptic membranes. Systemic administration facilitates the formation of long-term object recognition memory in mice and has a protective effect against brain ischemia and on reserpine-induced orofacial dyskinesia in rats. On the other hand, DPDS may be toxic, mainly because of its interaction with thiol groups. In the yeast Saccharomyces cerevisiae, the molecule acts as a pro-oxidant by depleting free glutathione. Administration to mice during cadmium intoxication has the opposite effect, reducing oxidative stress in various tissues. DPDS is a potent inhibitor of d-aminolevulinate dehydratase and chronic exposure to high doses of this compound has central effects on mouse brain, as well as liver and renal toxicity. Genotoxicity of this compound has been assessed in bacteria, haploid and diploid yeast and in a tumor cell line.
Subject(s)
Animals , Mice , Rats , Antioxidants/pharmacology , Benzene Derivatives/pharmacology , Organoselenium Compounds/pharmacology , Porphobilinogen Synthase/antagonists & inhibitors , Saccharomyces cerevisiae/drug effects , Benzene Derivatives/toxicity , Models, Biological , Mutagenicity Tests , Organoselenium Compounds/toxicityABSTRACT
Supply of cadmium chloride (0.5 mM) inhibited chlorophyll formation in greening maize leaf segments, while lower concentration of Cd (0.01 mM) slightly enhanced it. Inclusion of 2-oxoglutarate (2-OG, 0.1-10 mM) in the incubation mixture increased chlorophyll content in the absence as well as presence of Cd. Substantial inhibition of chlorophyll formation by Cd was observed at longer treatment both in the absence and presence of 2-OG. When the tissue was pre-incubated with 2-OG or Cd, the inhibition (%) of chlorophyll formation by Cd was lowered in the presence of 2-OG. Treatment with Cd inhibited ALAD activity and ALA formation and the inhibition (%) of ALA formation by Cd was strongly reduced in the presence of 2-OG. Glutamate dehydrogenase (GDH) activity was increased by the supply of Cd both in the absence as well as presence of 2-OG. In the presence of 2-OG, Cd supply significantly increased glutamate synthase (GOGAT) activity and reduced inhibition (%) of glutamine synthetase (GS) activity. The results suggested the involvement of the glutamine synthetase/glutamate synthase (GS/GOGAT) pathway of ammonia assimilation to provide the precursor, glutamate, for ALA synthesis under Cd toxicity and 2-OG supplementation.
Subject(s)
Aminolevulinic Acid/antagonists & inhibitors , Cadmium Chloride/pharmacology , Chlorophyll/antagonists & inhibitors , Ketoglutaric Acids/pharmacology , Plant Leaves/drug effects , Porphobilinogen Synthase/antagonists & inhibitors , Quaternary Ammonium Compounds/metabolism , Zea mays/drug effectsABSTRACT
A porfiria foi descrita pela primeira vez em 1874 pelo médico alemão J.H.Schultz. A maioria dos casos decorre de alterações genéticas (mutações), porém pode ser desencadeado por agentes tóxicos. O quadro clínico é variável, acarretando em fotossensibilidade cutânea e (ou) efeitos neurológicos, e é influenciado por fatores precipitantes, como hormônios, medicamentos e nutrição. Como as porfirias são raras e seus sintomas inespecíficos, o diagnóstico depende de um alto índice de suspeição. Infelizmente, ainda não há uma cura para a doença
Subject(s)
Humans , Porphyrias , Hydroxymethylbilane Synthase , Porphobilinogen SynthaseABSTRACT
O percentual de recuperação da enzima Ácido d-Aminolevulínico Desidratase (ALA-D) é um indicador de efeito sensível e específico para toxicidade ao chumbo mesmo a baixos níveis de chumbo em sangue (Pb-S). Atualmente, a saúde das crianças expostas ambientalmente às substâncias tóxicas tem sido objeto de grande atenção. Muitos estudos têm encontrado uma associação inversa entre o Pb-S e o crescimento ósseo. A homeostasia do cálcio é regulada pela ação do paratormônio (PTH), da Vitamina D e da Calcitonina, podendo o chumbo afetar aspectos deste metabolismo. O objetivo deste estudo foi avaliar os efeitos do chumbo sobre o metabolismo ósseo em crianças de 0 a 16 anos através da determinação da ALA-D em sangue e correlacionar com os níveis de PTH e fatores nutricionais. Este estudo foi realizado na comunidade João Goulard, em Manguinhos, no Rio de Janeiro. As amostras biológicas foram coletadas no Laboratório do CSEGSF/ENSP, onde os questionários de freqüência alimentar e sócio-econômicos foram aplicados. A determinação da atividade enzimática da ALA-D e do PTH foram realizados por Espectrofotometria e quimioluminescência, respectivamente...
Subject(s)
Humans , Male , Female , Infant, Newborn , Infant , Child, Preschool , Child , Adolescent , Adolescent Nutrition , Bone Density , Child Nutrition , Lead/toxicity , Environmental Exposure , Parathyroid Hormone/metabolism , Porphobilinogen Synthase/metabolism , Calcium, Dietary/metabolism , Lead/blood , Bone DevelopmentABSTRACT
Previous studies have suggested that delta-aminolevulinic acid dehydratase (ALAD) phenotype differently affect mineral metabolism. The objective of this study was to determine the effectiveness of 6-month iron supplementation as syrup of NaFeEDTA in improvement of iron status according to ALAD genotype. One hundred thirty adult women living in rural areas of Asan were provided NaFeEDTA syrup once a week for 6 months at the dose of 64mg Fe/week. Three hundred control subjects were observed during the study period. Fasting blood was obtained for analyzing hemoglobin (Hb) and zinc protophorphyrin (ZPP) and serum was analyzed for ferritin, iron and total iron capacity (TIBC) levels before and after iron supplementation. Ninety percent of ALAD 1-1 (ALAD1) and 10% of ALAD 1-2 (ALAD2) genotype were observed in the control group. However, in the intervention group, 98% showed ALAD1 while only 2% was ALAD2, which is significantly lower proportions of ALAD2 compared to the control group (p<0.01). The iron status of intervention group significantly improved except for ferritin and TIBC regardless of ALAD genotype, while the control group did not show any changes in iron status except for ZPP. ZPP concentration of the control group significantly increased in both ALAD1 and 2 while the intervention group showed significantly decreased ZPP after supplementation in ALAD1. Iron supplementation in the form of NaFeEDTA seems to be effective in reduction of ZPP levels although ALAD2 did not show significant changes due to the small number. However, it is difficult to make a conclusion from these results, and more specified further investigation is needed with more participants.
Subject(s)
Adult , Female , Humans , Fasting , Ferritins , Genotype , Clinical Trial , Iron , Metabolism , Nutritional Status , Phenotype , Porphobilinogen Synthase , ZincABSTRACT
Mercury (0.01-1.0 mM) inhibited chlorophyll formation in greening maize leaf segments. However, supplementing incubation medium with 2-oxoglutarate, maintained substantially higher level of chlorophyll in absence of metal after an initial period of 8 hr. On preincubation of leaf segments with HgCl2, per cent inhibition of chlorophyll synthesis by metal was same in the presence and absence of 2-oxoglutarate. Supply of 2-oxoglutarate (0.1-10.0 mM) exerted concentration dependent effect on chlorophyll formation in absence or presence of metal. Increase in delta-amino levulinic acid dehydratase as well as NADH-glutamate synthase activity and decrease in NADH-glutamate dehydrogenase activity by 2-oxoglutarate in the presence of Hg suggested that glutamate for delta-amino levulinic acid synthesis could be made available from NH4+ assimilation via., glutamine synthetase/glutamate synthase pathway during mercury toxicity.
Subject(s)
Aminolevulinic Acid/metabolism , Ammonia/metabolism , Chlorophyll/biosynthesis , Dose-Response Relationship, Drug , Glutamate Synthase/metabolism , Glutamic Acid/metabolism , Ketoglutaric Acids/pharmacology , Light , Mercury/toxicity , NAD/metabolism , Photosynthesis , Plant Leaves/drug effects , Porphobilinogen Synthase/metabolism , Radiation-Protective Agents/pharmacology , Zea mays/drug effectsABSTRACT
Lead pollution is considered as one of the major risk factors for pregnant women and children. In addition to its dangerous effect on growing youth, lead can accumulate in different organs in the human body. The biological effects of lead exposure in drinking water at different lead doses on male albino rats were investigated. Lead was given to rats in drinking water at 100, 500 and 1000 ppm for 7 weeks. It was observed that lead content was increased in kidneys, liver, brain, RBC's and serum by 26.7, 9.2, 10.7, 12.3 and 5.4-folds respectively at 1000 ppm lead dose compared with control group. It was observed that kidney accumulated very high concentration of lead as compared with other organs with a concomitant increase in serum creatinine in all lead exposed groups with the possibility of producing chronic renal failure. AST, ALT and creatinine were significantly increased by increasing the lead exposure dose. Also, the activity of delta-aminolevulinic acid dehydratase [delta ALAD] was significantly decreased by increasing lead exposure with a concomitant significant decrease in hemoglobin and hematocrite levels but with non-significant decrease in iron indicating the possibility that chronic lead exposure could produce anemia
Subject(s)
Male , Animals, Laboratory , Environmental Exposure , Liver Function Tests , Porphobilinogen Synthase/blood , Rats , Kidney/pathology , Brain/pathologyABSTRACT
<p><b>OBJECTIVE</b>The objective of this study was to investigate arsenic induced changes in blood delta-aminolevulinic acid dehydratase (ALAD) after in vitro and in vivo exposure to this element and its response to co-administration of meso 2,3-dimercaptosuccinic acid (DMSA) and monoisoamyl DMSA (MiADMSA) either individually or in combination.</p><p><b>METHODS</b>Rat whole blood was exposed to varying concentrations (0.1, 0.2 and 0.5 mmol/L) of arsenic (III) or arsenic (V), to assess their effects on blood ALAD activity. Varying concentrations of MiADMSA and DMSA (0.1, 0.5 and 1.0 mmol/L) were also tried in combination to determine its ability to mask the effect of arsenic induced (0.5 mmol/L) inhibition of blood ALAD in vitro. In vitro and in vivo experiments were also conducted to determine the effects of DMSA and MiADMSA either individually or in combination with arsenic, on blood ALAD activity and blood arsenic concentration.</p><p><b>RESULTS</b>In vitro experiments showed significant inhibition of the enzyme activity when 0.1-0.5 mmol/L of arsenic (III and V) was used. Treatment with MiADMSA increased ALAD activity when blood was incubated at the concentration of 0.1 mmol/L arsenic (III) and 0.1 mmol/L MiADMSA. No effect of 0.1 mmol/L MiADMSA on ALAD activity was noticed when the arsenic concentration was increased to 0.2 and 0.5 mmol/L. Similarly, MiADMSA at a lower concentration (0.1 mmol/L) was partially effective in the turnover of ALAD activity against 0.5 mmol/L arsenic (III), but at two higher concentrations (0.5 and 1.0 mmol/L) a complete restoration of ALAD activity was observed. DMSA at all the three concentrations (0.1, 0.5 and 1.0 mmol/L) was effective in restoring ALAD activity to the normal value.</p><p><b>CONCLUSIONS</b>The results thus suggest that arsenic has a distinct effect on ALAD activity. Another important toxicological finding of the present study, based on in vivo experiments further suggests that combined administration of DMSA and MiADMSA could be more beneficial for reducing blood ALAD inhibition and blood arsenic concentration than the individual treatment.</p>
Subject(s)
Animals , Male , Mice , Rats , Administration, Oral , Arsenic Poisoning , Blood , Arsenicals , Pharmacology , Enzyme Inhibitors , Pharmacology , Injections, Intraperitoneal , Porphobilinogen Synthase , Blood , Succimer , PharmacologyABSTRACT
OBJECTIVES: delta-Aminolevulinic acid dehydratase (ALAD) is a polymorphic enzyme that has two alleles, ALAD1 (ALAD1-1 as genotype) and ALAD2 (ALAD1-2 or ALAD2-2 as genotype). ALAD genotype has been reported to modify the pharmacokinetics and toxicity of lead. The authors investigated the influence of ALAD genotype polymorphism on renal function in lead workers METHODS: We studied 935 male lead workers and 87 male non-lead workers in the same industries. For cross-sectional renal indices, blood urea nitrogen (BUN), serum creatinine, serum uric acid and urine total protein were selected. Blood lead level was also measured an index of lead exposure. Information on weight, age, job duration, and smoking and drinking habits was collected. RESULTS: Whereas the mean blood lead level of lead workers was 25.4+/-10.9 microgram/dL, that of non-lead workers in the same premise was 10.1+/-2.8 microgram/dL, and the difference between the two groups was statistically significant. Whereas the prevalence of the variant allele, ALAD2 in 935 lead workers was 10.6%, that in 87 non-lead workers was 4.6%. However there was no difference of prevalence between the two groups. The mean blood lead level of subjects with ALAD1 was 23.9+/-11.4 microgram/dL, which was slightly lower than that of subjects with ALAD2 (25.8+/-10.7 microgram/dL). However, this difference was not statistically significant. After adjustment for the covariates, the subjects with ALAD2 allele were 12.8% less likely to have a median value or more of BUN than subject with ALAD1. The adjusted odds ratio was 0.59 (95% confidence interval; 0.38-0.91). After adjustment for the covariates, the subjects with ALAD2 allele were 9.3% less likely to have a median value or more of serum creatinine than subject with ALAD1. The adjusted odds ratio was 0.64 (95% confidence interval; 0.41-0.98). CONCLUSIONS: From the above results, it was found that the variant allele, ALAD2 appeared to modify the association of lead and renal function, and that ALAD2 genotype may be supportive for the protective effect of lead.
Subject(s)
Humans , Male , Alleles , Blood Urea Nitrogen , Creatinine , Drinking , Genotype , Odds Ratio , Pharmacokinetics , Porphobilinogen Synthase , Prevalence , Smoke , Smoking , Uric AcidABSTRACT
Varied concentrations of PbCl2 and CdCl2 in the germinating media reduced the total chlorophyll and carotenoid contents in primary leaves of Amaranthus lividus seedlings (168 h old). When chlorophyll a and chlorophyll b contents were measured separately, greater loss of chl b than chl a under the identical conditions of heavy metal treatment was observed In addition, the loss of total chlorophyll was more than carotenoids under the same magnitude of heavy metal treatment. The effect of heavy metal treatment at germination stage was further studied on chlorophyll accumulation in primary leaves in relation to the activities of 5-aminolevulinic acid dehydratase (ALAD) and chlorophyllase. The activities of ALAD gradually diminished in response to both the heavy metals in a concentration-guided manner, while the activities of chlorophyllase did not exhibit any significant change.
Subject(s)
Amaranthus/drug effects , Carboxylic Ester Hydrolases/metabolism , Carotenoids/metabolism , Chlorophyll/metabolism , Dose-Response Relationship, Drug , Metals, Heavy/toxicity , Plant Leaves/drug effects , Porphobilinogen Synthase/metabolism , Spectrophotometry, Ultraviolet , Time FactorsABSTRACT
We evaluated the porphyrinogenic ability of ethanol (20 percent in drinking water) per se, its effect on the development of sporadic porphyria cutanea tarda induced by hexachlorobenzene in female Wistar rats (170-190 g, N = 8/group), and the relationship with hepatic damage. Twenty-five percent of the animals receiving ethanol increased up to 14-, 25-, and 4.5-fold the urinary excretion of delta-aminolevulinate, porphobilinogen, and porphyrins, respectively. Ethanol exacerbated the precursor excretions elicited by hexachlorobenzene. Hepatic porphyrin levels increased by hexachlorobenzene treatment, while this parameter only increased (up to 90-fold) in some of the animals that received ethanol alone. Ethanol reduced the activities of uroporphyrinogen decarboxylase, delta-aminolevulinate dehydrase and ferrochelatase. In the ethanol group, many of the animals showed a 30 percent decrease in uroporphyrinogen activity; in the ethanol + hexachlorobenzene group, this decrease occurred before the one caused by hexachlorobenzene alone. Ethanol exacerbated the effects of hexachlorobenzene, among others, on the rate-limiting enzyme delta-aminolevulinate synthetase. The plasma activities of enzymes that are markers of hepatic damage were similar in all drug-treated groups. These results indicate that 1) ethanol exacerbates the biochemical manifestation of sporadic hexachlorobenzene-induced porphyria cutanea tarda; 2) ethanol per se affects several enzymatic and excretion parameters of the heme metabolic pathway; 3) since not all the animals were affected to the same extent, ethanol seems to be a porphyrinogenic agent only when there is a predisposition, and 4) hepatic damage showed no correlation with the development of porphyria cutanea tarda
Subject(s)
Animals , Female , Rats , Ethanol , Ferrochelatase , Liver , Porphyria Cutanea Tarda , Uroporphyrinogen Decarboxylase , /analysis , Disease Models, Animal , Ferrochelatase , Hexachlorobenzene , Liver , Porphobilinogen , Porphobilinogen Synthase , Porphyria Cutanea Tarda , Porphyrins , Rats, Wistar , Uroporphyrinogen DecarboxylaseABSTRACT
The interaction of the product of H2O2 and (PhSe)2 with delta-aminolevulinate dehydratase (delta-ALA-D) from mammals and plants was investigated. (PhSe)2 inhibited rat hepatic delta-ALA-D with an IC50 of 10 æM but not the enzyme from cucumber leaves. The reaction of (PhSe)2 with H2O2 for 1 h increased the inhibitory potency of the original compound and the IC50 for animal delta-ALA-D inhibition was decreased from 10 to 2 æM. delta-ALA-D from cucumber leaves was also inhibited by the products of reaction of (PhSe)2 with H2O2 with an IC50 of 4 æM. The major product of reaction of (PhSe)2 with H2O2 was identified as seleninic acid and produced an intermediate with a lambdamax at 265 nm after reaction with t-BuSH. These results suggest that the interaction of (PhSe)2 with mammal delta-ALA-D requires the presence of cysteinyl residues in close proximity. Two cysteine residues in spatial proximity have been recently described for the mammalian enzyme. Analysis of the primary structure of plant delta-ALA-D did not reveal an analogous site. In contrast to (PhSe)2, seleninic acid, as a result of the higher electrophilic nature of its selenium atom, may react with additional cysteinyl residue(s) in mammalian delta-ALA-D and also with cysteinyl residues from cucumber leaves located at a site distinct from that found at the B and A sites in mammals. Although the interaction of organochalcogens with H2O2 may have some antioxidant properties, the formation of seleninic acid as a product of this reaction may increase the toxicity of organic chalcogens such as (PhSe)2
Subject(s)
Animals , Cattle , Rats , Cucumis sativus , Hydrogen Peroxide , Liver , Organoselenium Compounds , Porphobilinogen Synthase , Analysis of VarianceABSTRACT
<p><b>OBJECTIVE</b>The relationship between polymorphisms of ALAD and VDR genes and individual susceptibility of lead poisoning was investigated in children highly-exposed to lead.</p><p><b>METHOD</b>Four hundred and sixty-nine children were recruited into this study and the blood lead, ZPP, hemoglobin as well as three physical developmental indexes (head circumference, height and weight) were measured. VDR and ALAD gene polymorphisms were analyzed by the methods of PCR-RFLP.</p><p><b>RESULTS</b>The subjects with ALAD2 allele had higher ZPP level (10.12 micro mol/L vs 12.87 micro mol/L) (P = 0.017). The subjects with B allele has larger head circumference than only with b allele (51.19 cm vs 50.75 cm) (P = 0.028).</p><p><b>CONCLUSIONS</b>It was suggested that the ALAD gene polymorphism modified the relationship between blood lead and ZPP and the VDR gene variants influenced the skull development in children living under lead-polluted environment. The polymorphism of ALAD and VDR genes might serve as the molecular inherited factors modifying the susceptibility of lead poisoning.</p>
Subject(s)
Child , Female , Humans , Male , Alleles , Body Height , Genetics , Body Weight , Genetics , China , Epidemiology , Environmental Pollution , Gene Frequency , Genotype , Lead , Blood , Lead Poisoning , Epidemiology , Genetics , Polymorphism, Genetic , Porphobilinogen Synthase , Genetics , Receptors, Calcitriol , GeneticsABSTRACT
<p><b>OBJECTIVE</b>To investigate the polymorphism of delta-aminolevulinic acid dehydratase(ALAD) and the genetic susceptibility to lead toxicity in Uighur and Yi population in China.</p><p><b>METHODS</b>The ALAD genotypes were determined by PCR and MspI restriction fragment length polymorphism techniques in 214 Uighur individuals from Xinjiang autonomous region and 144 Yi individuals from Yunnan province. The correlation between the polymorphism of ALAD and blood lead levels, and the factors affecting the latter were explored.</p><p><b>RESULTS</b>The frequencies of the allele ALAD1 and ALAD2 in Uighur are 0.91 and 0.09; and in Yi are 0.98 and 0.02 respectively. In Uighur the average blood lead level was (76 +/- 4) microgram/L, and 25.7% individuals with blood lead level > or = 100 micrograms/L. In Yi the average blood lead level was (50 +/- 16) microgram/L, and 6.3% individuals with blood lead level > or = 100 micrograms/L. However, no statistic correlation between the distribution of ALAD alleles and the blood lead level was found in both populations.</p><p><b>CONCLUSION</b>The genetic susceptibility of ALAD polymorphism to lead toxicity may exhibit in a lead dose-dependent manner.</p>
Subject(s)
Humans , China , Ethnology , Dose-Response Relationship, Drug , Genetic Predisposition to Disease , Lead , Blood , Toxicity , Polymorphism, Genetic , Porphobilinogen Synthase , GeneticsABSTRACT
Con el objeto de desarrollar un modelo en embriones de aves para el estudio de la acción porfirinogénica de drogas, se realizaron estudios ontogénicos y físico-químicos en l saco vitelono (SV) e hígados de embriones de pollos, en función de los días de desarrollo embrionario. Se determinaron los niveles de la enzima &-Aminolevúlico dehidrasa (ALA-D) en ambos tejidos, encontrando en los dos un máximo de actividad específica a los 12 días de incubación, siendo en SV siempre mayor que en hígado. En el hígado, la actividad enzimática total, así como el contenido de proteínas totales y el peso del órgano, están de acuerdo con la tasa crecimiento y los cambios en su metabolismo general, durante el desarrollo embrionario. La actividad enzimática total SV presenta un máximo entre los 12 y 13 días de incubación, declinando durante la última semana. El contenido de proteínas totales, no varía durante la incubación. El peso seco aumente hasta el día 17 registrando luego una disminución, debido a la retracción del saco hacia el interior del embrión, Este cambvio puede apreciarse considerando el peso húmedo, debido a que el aumento de materiales adherentes en la yema dificulta su remoción. El pH óptimo resultó igual a 6,8 para ambos tejidos. Mostraron diferencias en cuanto a la termoestabilidad, que resulto mayor para la enzima de SV, copmo puede verse a través de sus energías de activación (Ea). La estabilidad térmica de la enzima SV se incrementó por protección del sitio activo o por el mantenimiento de sus grupos sulfhidrílicos reducidos. Estudios cinéticos revelan mayor afinidad por el sustrato porb la enzima de SV (Kmh= 0,29 mM y Kmsv= o,026 mM). El SV resulta una fuente atrayente para la caracterización de las enzimas cisólicas del camino biosintético del hemo, en vistas de proponber un modelo experimental útil para el ensayo de drogas porfirinogénicas y poder establecer así su modo de acción(AB)
Subject(s)
Animals , Chick Embryo , Chick Embryo , Liver/enzymology , Porphyrinogens/administration & dosage , Porphobilinogen Synthase , Yolk Sac/chemistryABSTRACT
Lead has been shown to produce cognitive and motor deficits in young rats that could be mediated, at least in part, by inhibition of the zinc-containing heme biosynthetic enzyme delta-aminolevulinate dehydratase (ALA-D). In the present study we investigated the effects of lead and/or zinc treatment during the second stage of rapid postnatal brain development on brain, kidney and blood ALA-D specific activity, as well as the negative geotaxis behavior of rats. Eight-day-old Wistar rats were injected intraperitoneally with saline, lead acetate (8 mg/kg) and/or zinc chloride (2 mg/kg) daily for five consecutive days. Twenty-four hours after treatment, ALA-D activity was determined in the absence and presence of DL-dithiothreitol (DTT). The negative geotaxis behavior was assessed in 9- to 13-day-old rats. Treatment with lead and/or zinc did not affect body, brain or kidney weights or brain- or kidney-to-body weight ratios of the animals. In spite of the absence of effect of any treatment on ALA-D specific activity in brain, kidney and blood, the reactivation index with DTT was higher in the groups treated with lead or lead + zinc than in the control group, in brain, kidney and blood (mean + or - SEM; brain: 33.33 + or - 4.34, 38.90 + or - 8.24, 13.67 + or - 3.41; kidney: 33.50 + or - 2.97, 37.60 + or - 2.67, 15.80 + or - 2.66; blood: 63.95 + or - 3.73, 56.43 + or - 5.93, 31.07 + or - 4.61, respectively, N = 9-11). The negative geotaxis response behavior was not affected by lead and/or zinc treatment. The results indicate that lead and/or zinc treatment during the second stage of rapid postnatal brain growth affected ALA-D, but zinc was not sufficient to protect the enzyme from the effects of lead in brain, kidney and blood.